http://www.cardiosource.com/cjrpicks/CJRPick.asp?cjrID=5741&...
Submitted by
cardiologylinks
4 months, 2 weeks, 8 hours ago
In two trials, the investigators randomly assigned a total of 2,701 patients who had received DES and had been free of major adverse cardiac or cerebrovascular events and major bleeding for a period of at least 12 months to receive clopidogrel plus aspirin or aspirin alone. The primary endpoint was . . .